Difference between revisions of "Stub"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m
m (Text replacement - "{| class="wikitable" style="float:right; margin-left: 5px;" |- |back to top |}" to "")
Line 7: Line 7:
 
=Regimens composed solely of approved drugs=
 
=Regimens composed solely of approved drugs=
 
==3M==
 
==3M==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
3M: '''<u>M</u>'''itomycin, '''<u>M</u>'''itoxantrone, '''<u>M</u>'''ethotrexate
 
3M: '''<u>M</u>'''itomycin, '''<u>M</u>'''itoxantrone, '''<u>M</u>'''ethotrexate
 
===Regimen===
 
===Regimen===
Line 19: Line 16:
  
 
==5-FU & RT==
 
==5-FU & RT==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Chemotherapy====
 
====Chemotherapy====
Line 30: Line 24:
  
 
==7+3i & Clofarabine==
 
==7+3i & Clofarabine==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
7+3i & Clofarabine: '''<u>7</u>''' days of cytarabine, '''<u>3</u>''' days of '''<u>i</u>'''darubicin, Clofarabine
 
7+3i & Clofarabine: '''<u>7</u>''' days of cytarabine, '''<u>3</u>''' days of '''<u>i</u>'''darubicin, Clofarabine
 
===Regimen===
 
===Regimen===
Line 42: Line 33:
  
 
==7+3i & Lenalidomide==
 
==7+3i & Lenalidomide==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
7+3i & Lenalidomide: '''<u>7</u>''' days of cytarabine, '''<u>3</u>''' days of '''<u>i</u>'''darubicin, Lenalidomide
 
7+3i & Lenalidomide: '''<u>7</u>''' days of cytarabine, '''<u>3</u>''' days of '''<u>i</u>'''darubicin, Lenalidomide
 
===Regimen===
 
===Regimen===
Line 55: Line 43:
  
 
==7+4i==
 
==7+4i==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
7+4i: '''<u>7</u>''' days of cytarabine, '''<u>4</u>''' days of '''<u>i</u>'''darubicin
 
7+4i: '''<u>7</u>''' days of cytarabine, '''<u>4</u>''' days of '''<u>i</u>'''darubicin
 
===Regimen===
 
===Regimen===
Line 66: Line 51:
  
 
==7+5d==
 
==7+5d==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
7+5d: '''<u>7</u>''' days of cytarabine, '''<u>5</u>''' days of '''<u>d</u>'''aunorubicin
 
7+5d: '''<u>7</u>''' days of cytarabine, '''<u>5</u>''' days of '''<u>d</u>'''aunorubicin
 
===Regimen===
 
===Regimen===
Line 77: Line 59:
  
 
==Abiraterone & Enzalutamide==
 
==Abiraterone & Enzalutamide==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Endocrine therapy====
 
====Endocrine therapy====
Line 87: Line 66:
  
 
==ABVP==
 
==ABVP==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Chemotherapy====
 
====Chemotherapy====
Line 99: Line 75:
  
 
==ACP==
 
==ACP==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
ACP: '''<u>A</u>'''tezolizumab, '''<u>C</u>'''arboplatin, '''<u>P</u>'''aclitaxel
 
ACP: '''<u>A</u>'''tezolizumab, '''<u>C</u>'''arboplatin, '''<u>P</u>'''aclitaxel
 
===Regimen===
 
===Regimen===
Line 112: Line 85:
  
 
==Afatinib & Vinorelbine==
 
==Afatinib & Vinorelbine==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Chemotherapy====
 
====Chemotherapy====
Line 123: Line 93:
  
 
==A-ICE==
 
==A-ICE==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
A-ICE: '''<u>A</u>'''TRA, '''<u>I</u>'''darubicin, '''<u>C</u>'''ytarabine, '''<u>E</u>'''toposide
 
A-ICE: '''<u>A</u>'''TRA, '''<u>I</u>'''darubicin, '''<u>C</u>'''ytarabine, '''<u>E</u>'''toposide
 
===Regimen===
 
===Regimen===
Line 137: Line 104:
  
 
==AME==
 
==AME==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
AME: '''<u>A</u>'''ra-C (Cytarabine), '''<u>M</u>'''itoxantrone, '''<u>E</u>'''toposide
 
AME: '''<u>A</u>'''ra-C (Cytarabine), '''<u>M</u>'''itoxantrone, '''<u>E</u>'''toposide
 
===Regimen===
 
===Regimen===
Line 149: Line 113:
  
 
==Amsacrine & IDAC==
 
==Amsacrine & IDAC==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
Amsacrine & IDAC: Amsacrine & '''<u>I</u>'''ntermediate '''<u>D</u>'''ose '''<u>A</u>'''ra-'''<u>C</u>''' (Cytarabine)
 
Amsacrine & IDAC: Amsacrine & '''<u>I</u>'''ntermediate '''<u>D</u>'''ose '''<u>A</u>'''ra-'''<u>C</u>''' (Cytarabine)
 
===Regimen===
 
===Regimen===
Line 160: Line 121:
  
 
==ATRA, Cytarabine, Etoposide==
 
==ATRA, Cytarabine, Etoposide==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Targeted therapy====
 
====Targeted therapy====
Line 172: Line 130:
  
 
==AVML==
 
==AVML==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Chemotherapy====
 
====Chemotherapy====
Line 185: Line 140:
  
 
==Binimetinib monotherapy==
 
==Binimetinib monotherapy==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Targeted therapy====
 
====Targeted therapy====
Line 194: Line 146:
  
 
==Bortezomib & Bevacizumab==
 
==Bortezomib & Bevacizumab==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
{| class="wikitable sortable" style="width: 100%; text-align:center;"  
 
{| class="wikitable sortable" style="width: 100%; text-align:center;"  
Line 218: Line 167:
  
 
==Bortezomib & Siltuximab==
 
==Bortezomib & Siltuximab==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
{| class="wikitable sortable" style="width: 100%; text-align:center;"  
 
{| class="wikitable sortable" style="width: 100%; text-align:center;"  
Line 242: Line 188:
  
 
==BTH (Docetaxel)==
 
==BTH (Docetaxel)==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
BTH: '''<u>B</u>'''evacizumab, '''<u>T</u>'''axotere (Docetaxel), '''<u>H</u>'''erceptin (Trastuzumab)
 
BTH: '''<u>B</u>'''evacizumab, '''<u>T</u>'''axotere (Docetaxel), '''<u>H</u>'''erceptin (Trastuzumab)
 
===Regimen===
 
===Regimen===
Line 255: Line 198:
  
 
==BTOC==
 
==BTOC==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
BTOC: '''<u>B</u>'''CNU, '''<u>T</u>'''hiotepa, '''<u>O</u>'''ncovin (Vincristine), '''<u>C</u>'''yclophosphamide
 
BTOC: '''<u>B</u>'''CNU, '''<u>T</u>'''hiotepa, '''<u>O</u>'''ncovin (Vincristine), '''<u>C</u>'''yclophosphamide
 
===Regimen===
 
===Regimen===
Line 268: Line 208:
  
 
==CAD==
 
==CAD==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
CAD: '''<u>C</u>'''yclophosphamide, '''<u>A</u>'''driamycin (Doxorubicin), '''<u>D</u>'''DP (Cisplatin)
 
CAD: '''<u>C</u>'''yclophosphamide, '''<u>A</u>'''driamycin (Doxorubicin), '''<u>D</u>'''DP (Cisplatin)
 
===Regimen===
 
===Regimen===
Line 280: Line 217:
  
 
==Capecitabine & Cisplatin (CX) & Bevacizumab==
 
==Capecitabine & Cisplatin (CX) & Bevacizumab==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Chemotherapy====
 
====Chemotherapy====
Line 292: Line 226:
  
 
==Capecitabine & Cisplatin (CX) & Ramucirumab==
 
==Capecitabine & Cisplatin (CX) & Ramucirumab==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Chemotherapy====
 
====Chemotherapy====
Line 304: Line 235:
  
 
==Capecitabine & Ruxolitinib==
 
==Capecitabine & Ruxolitinib==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Chemotherapy====
 
====Chemotherapy====
Line 315: Line 243:
  
 
==Capecitabine & Sorafenib==
 
==Capecitabine & Sorafenib==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Chemotherapy====
 
====Chemotherapy====
Line 326: Line 251:
  
 
==Capecitabine & Sunitinib==
 
==Capecitabine & Sunitinib==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Chemotherapy====
 
====Chemotherapy====
Line 337: Line 259:
  
 
==Capecitabine & Vinflunine==
 
==Capecitabine & Vinflunine==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Chemotherapy====
 
====Chemotherapy====
Line 347: Line 266:
  
 
==Capecitabine & Vinorelbine (NX)==
 
==Capecitabine & Vinorelbine (NX)==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
NX: '''<u>N</u>'''avelbine (Vinorelbine) & '''<u>X</u>'''eloda (Capecitabine)
 
NX: '''<u>N</u>'''avelbine (Vinorelbine) & '''<u>X</u>'''eloda (Capecitabine)
 
===Regimen===
 
===Regimen===
Line 358: Line 274:
  
 
==Capecitabine, Cisplatin, Cetuximab, RT==
 
==Capecitabine, Cisplatin, Cetuximab, RT==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Chemotherapy====
 
====Chemotherapy====
Line 372: Line 285:
  
 
==Capecitabine, Erlotinib, RT==
 
==Capecitabine, Erlotinib, RT==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Chemotherapy====
 
====Chemotherapy====
Line 385: Line 295:
  
 
==CarboMIP==
 
==CarboMIP==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
CarboMIP: '''<u>Carbo</u>'''platin, '''<u>M</u>'''itomycin, '''<u>I</u>'''fosfamide, '''<u>P</u>'''latinol (Cisplatin)
 
CarboMIP: '''<u>Carbo</u>'''platin, '''<u>M</u>'''itomycin, '''<u>I</u>'''fosfamide, '''<u>P</u>'''latinol (Cisplatin)
 
===Regimen===
 
===Regimen===
Line 398: Line 305:
  
 
==Carboplatin & Epirubicin==
 
==Carboplatin & Epirubicin==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Chemotherapy====
 
====Chemotherapy====
Line 408: Line 312:
  
 
==Carboplatin & Paclitaxel (CP) & Bexarotene==
 
==Carboplatin & Paclitaxel (CP) & Bexarotene==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
CP & Bexarotene: '''<u>C</u>'''arboplatin, '''<u>P</u>'''aclitaxel, Bexarotene
 
CP & Bexarotene: '''<u>C</u>'''arboplatin, '''<u>P</u>'''aclitaxel, Bexarotene
 
===Regimen===
 
===Regimen===
Line 420: Line 321:
  
 
==Carboplatin & Paclitaxel (CP) & Cetuximab==
 
==Carboplatin & Paclitaxel (CP) & Cetuximab==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
CP & Cetuximab: '''<u>C</u>'''arboplatin, '''<u>P</u>'''aclitaxel, Cetuximab
 
CP & Cetuximab: '''<u>C</u>'''arboplatin, '''<u>P</u>'''aclitaxel, Cetuximab
 
===Regimen===
 
===Regimen===
Line 433: Line 331:
  
 
==Carboplatin & Paclitaxel (CP) & Erlotinib==
 
==Carboplatin & Paclitaxel (CP) & Erlotinib==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
CP & Erlotinib: '''<u>C</u>'''arboplatin, '''<u>P</u>'''aclitaxel, Erlotinib
 
CP & Erlotinib: '''<u>C</u>'''arboplatin, '''<u>P</u>'''aclitaxel, Erlotinib
 
===Regimen===
 
===Regimen===
Line 446: Line 341:
  
 
==Carboplatin & Paclitaxel (CP) & Pegylated liposomal doxorubicin==
 
==Carboplatin & Paclitaxel (CP) & Pegylated liposomal doxorubicin==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
CP & PLD: '''<u>C</u>'''arboplatin, '''<u>P</u>'''aclitaxel, '''<u>P</u>'''egylated '''<u>L</u>'''iposomal '''<u>D</u>'''oxorubicin
 
CP & PLD: '''<u>C</u>'''arboplatin, '''<u>P</u>'''aclitaxel, '''<u>P</u>'''egylated '''<u>L</u>'''iposomal '''<u>D</u>'''oxorubicin
 
<br>TC & PLD: '''<u>T</u>'''axol (Paclitaxel), '''<u>C</u>'''arboplatin, '''<u>P</u>'''egylated '''<u>L</u>'''iposomal '''<u>D</u>'''oxorubicin
 
<br>TC & PLD: '''<u>T</u>'''axol (Paclitaxel), '''<u>C</u>'''arboplatin, '''<u>P</u>'''egylated '''<u>L</u>'''iposomal '''<u>D</u>'''oxorubicin
Line 459: Line 351:
  
 
==Carboplatin & Paclitaxel (CP) & Sorafenib==
 
==Carboplatin & Paclitaxel (CP) & Sorafenib==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
CP & Sorafenib: '''<u>C</u>'''arboplatin, '''<u>P</u>'''aclitaxel, Sorafenib
 
CP & Sorafenib: '''<u>C</u>'''arboplatin, '''<u>P</u>'''aclitaxel, Sorafenib
 
===Regimen===
 
===Regimen===
Line 472: Line 361:
  
 
==Carboplatin & Paclitaxel (CP) & Topotecan==
 
==Carboplatin & Paclitaxel (CP) & Topotecan==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
TC & Topotecan: '''<u>T</u>'''axol (Paclitaxel), '''<u>C</u>'''arboplatin, Topotecan
 
TC & Topotecan: '''<u>T</u>'''axol (Paclitaxel), '''<u>C</u>'''arboplatin, Topotecan
 
===Regimen===
 
===Regimen===
Line 484: Line 370:
  
 
==Carboplatin & Topotecan==
 
==Carboplatin & Topotecan==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Chemotherapy====
 
====Chemotherapy====
Line 494: Line 377:
  
 
==CBM==
 
==CBM==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
CBM: '''<u>C</u>'''apecitabine, '''<u>B</u>'''evacizumab, '''<u>M</u>'''itomycin
 
CBM: '''<u>C</u>'''apecitabine, '''<u>B</u>'''evacizumab, '''<u>M</u>'''itomycin
 
===Regimen===
 
===Regimen===
Line 507: Line 387:
  
 
==CCG==
 
==CCG==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
CCG: '''<u>C</u>'''isplatin, '''<u>C</u>'''arboplatin, '''<u>G</u>'''emcitabine
 
CCG: '''<u>C</u>'''isplatin, '''<u>C</u>'''arboplatin, '''<u>G</u>'''emcitabine
 
===Regimen===
 
===Regimen===
Line 519: Line 396:
  
 
==Carboplatin & Etoposide (CE) & Ipilimumab==
 
==Carboplatin & Etoposide (CE) & Ipilimumab==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
CE & Ipilimumab: '''<u>C</u>'''arboplatin, '''<u>E</u>'''toposide, Ipilimumab
 
CE & Ipilimumab: '''<u>C</u>'''arboplatin, '''<u>E</u>'''toposide, Ipilimumab
 
===Regimen===
 
===Regimen===
Line 532: Line 406:
  
 
==Carboplatin & Etoposide (CE) & Thalidomide==
 
==Carboplatin & Etoposide (CE) & Thalidomide==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
CE & Thalidomide: '''<u>C</u>'''arboplatin, '''<u>E</u>'''toposide, Thalidomide
 
CE & Thalidomide: '''<u>C</u>'''arboplatin, '''<u>E</u>'''toposide, Thalidomide
 
===Regimen===
 
===Regimen===
Line 545: Line 416:
  
 
==CIB==
 
==CIB==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
CIB: '''<u>C</u>'''isplatin, '''<u>I</u>'''fosfamide, '''<u>B</u>'''leomycin
 
CIB: '''<u>C</u>'''isplatin, '''<u>I</u>'''fosfamide, '''<u>B</u>'''leomycin
 
===Regimen===
 
===Regimen===
Line 557: Line 425:
  
 
==Cisplatin & Methotrexate==
 
==Cisplatin & Methotrexate==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Chemotherapy====
 
====Chemotherapy====
Line 567: Line 432:
  
 
==Cisplatin & Treosulfan==
 
==Cisplatin & Treosulfan==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Chemotherapy====
 
====Chemotherapy====
Line 577: Line 439:
  
 
==Cisplatin & Vincristine==
 
==Cisplatin & Vincristine==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Chemotherapy====
 
====Chemotherapy====
Line 587: Line 446:
  
 
==Cisplatin, Avelumab, RT==
 
==Cisplatin, Avelumab, RT==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Chemotherapy====
 
====Chemotherapy====
Line 600: Line 456:
  
 
==Cisplatin, Pemetrexed, RT==
 
==Cisplatin, Pemetrexed, RT==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Chemotherapy====
 
====Chemotherapy====
Line 612: Line 465:
  
 
==CODE==
 
==CODE==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
CODE: '''<u>C</u>'''isplatin, '''<u>O</u>'''ncovin (Vincristine), '''<u>D</u>'''oxorubicin, '''<u>E</u>'''toposide
 
CODE: '''<u>C</u>'''isplatin, '''<u>O</u>'''ncovin (Vincristine), '''<u>D</u>'''oxorubicin, '''<u>E</u>'''toposide
 
===Regimen===
 
===Regimen===
Line 625: Line 475:
  
 
==CYVADIC==
 
==CYVADIC==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
CYVADIC: '''<u>CY</u>'''clophosphamide, '''<u>V</u>'''incristine, '''<u>AD</u>'''riamycin (Doxorubicin), '''<u>I</u>'''midazole '''<u>C</u>'''arboxamide (Dacarbazine)
 
CYVADIC: '''<u>CY</u>'''clophosphamide, '''<u>V</u>'''incristine, '''<u>AD</u>'''riamycin (Doxorubicin), '''<u>I</u>'''midazole '''<u>C</u>'''arboxamide (Dacarbazine)
 
===Regimen===
 
===Regimen===
Line 638: Line 485:
  
 
==DBCT==
 
==DBCT==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
DBCT: '''<u>D</u>'''acarbazine, '''<u>B</u>'''CNU (Carmustine), '''<u>C</u>'''isplatin, '''<u>T</u>'''amoxifen
 
DBCT: '''<u>D</u>'''acarbazine, '''<u>B</u>'''CNU (Carmustine), '''<u>C</u>'''isplatin, '''<u>T</u>'''amoxifen
 
===Regimen===
 
===Regimen===
Line 652: Line 496:
  
 
==Docetaxel & Gefitinib==
 
==Docetaxel & Gefitinib==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Chemotherapy====
 
====Chemotherapy====
Line 663: Line 504:
  
 
==Docetaxel & Lapatinib (TL)==
 
==Docetaxel & Lapatinib (TL)==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
TL: '''<u>T</u>'''axotere (Docetaxel) & '''<u>L</u>'''apatinib
 
TL: '''<u>T</u>'''axotere (Docetaxel) & '''<u>L</u>'''apatinib
 
===Regimen===
 
===Regimen===
Line 675: Line 513:
  
 
==Docetaxel & Pertuzumab==
 
==Docetaxel & Pertuzumab==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Chemotherapy====
 
====Chemotherapy====
Line 686: Line 521:
  
 
==Docetaxel & Selumetinib==
 
==Docetaxel & Selumetinib==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Chemotherapy====
 
====Chemotherapy====
Line 697: Line 529:
  
 
==Docetaxel & Sunitinib==
 
==Docetaxel & Sunitinib==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Chemotherapy====
 
====Chemotherapy====
Line 708: Line 537:
  
 
==Docetaxel & ziv-Aflibercept==
 
==Docetaxel & ziv-Aflibercept==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Chemotherapy====
 
====Chemotherapy====
Line 719: Line 545:
  
 
==Doxorubicin & Etoposide==
 
==Doxorubicin & Etoposide==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Chemotherapy====
 
====Chemotherapy====
Line 729: Line 552:
  
 
==Doxorubicin & Paclitaxel==
 
==Doxorubicin & Paclitaxel==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Chemotherapy====
 
====Chemotherapy====
Line 739: Line 559:
  
 
==Doxorubicin & Sorafenib==
 
==Doxorubicin & Sorafenib==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Chemotherapy====
 
====Chemotherapy====
Line 750: Line 567:
  
 
==Doxorubicin & Streptozocin==
 
==Doxorubicin & Streptozocin==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Chemotherapy====
 
====Chemotherapy====
Line 760: Line 574:
  
 
==Doxorubicin & Vinorelbine==
 
==Doxorubicin & Vinorelbine==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Chemotherapy====
 
====Chemotherapy====
Line 770: Line 581:
  
 
==EAP==
 
==EAP==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
EAP: '''<u>E</u>'''toposide, '''<u>A</u>'''driamycin (Doxorubicin), '''<u>P</u>'''latinol (Cisplatin)
 
EAP: '''<u>E</u>'''toposide, '''<u>A</u>'''driamycin (Doxorubicin), '''<u>P</u>'''latinol (Cisplatin)
 
===Regimen===
 
===Regimen===
Line 782: Line 590:
  
 
==ECVBP==
 
==ECVBP==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
ECVBP: '''<u>E</u>'''pirubicin, '''<u>C</u>'''yclophosphamide, '''<u>V</u>'''indesine, '''<u>B</u>'''leomycin, '''<u>P</u>'''rednisone
 
ECVBP: '''<u>E</u>'''pirubicin, '''<u>C</u>'''yclophosphamide, '''<u>V</u>'''indesine, '''<u>B</u>'''leomycin, '''<u>P</u>'''rednisone
 
===Regimen===
 
===Regimen===
Line 796: Line 601:
  
 
==ELF==
 
==ELF==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
ELF: '''<u>E</u>'''toposide, '''<u>L</u>'''eucovorin, 5-'''<u>F</u>'''U
 
ELF: '''<u>E</u>'''toposide, '''<u>L</u>'''eucovorin, 5-'''<u>F</u>'''U
 
===Regimen===
 
===Regimen===
Line 808: Line 610:
  
 
==Encorafenib monotherapy==
 
==Encorafenib monotherapy==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Targeted therapy====
 
====Targeted therapy====
Line 817: Line 616:
  
 
==EP & Ipilimumab==
 
==EP & Ipilimumab==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
EP & Ipilimumab: '''<u>E</u>'''toposide, '''<u>P</u>'''latinol (Cisplatin), Ipilimumab
 
EP & Ipilimumab: '''<u>E</u>'''toposide, '''<u>P</u>'''latinol (Cisplatin), Ipilimumab
 
===Regimen===
 
===Regimen===
Line 830: Line 626:
  
 
==EP, Tamoxifen, RT==
 
==EP, Tamoxifen, RT==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
EP, Tamoxifen, RT: '''<u>E</u>'''toposide, '''<u>P</u>'''latinol (Cisplatin), Tamoxifen, '''<u>R</u>'''adiation '''<u>T</u>'''herapy
 
EP, Tamoxifen, RT: '''<u>E</u>'''toposide, '''<u>P</u>'''latinol (Cisplatin), Tamoxifen, '''<u>R</u>'''adiation '''<u>T</u>'''herapy
 
===Regimen===
 
===Regimen===
Line 845: Line 638:
  
 
==Erlotinib & Sunitinib==
 
==Erlotinib & Sunitinib==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Targeted therapy====
 
====Targeted therapy====
Line 855: Line 645:
  
 
==Everolimus & Vinorelbine==
 
==Everolimus & Vinorelbine==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Chemotherapy====
 
====Chemotherapy====
Line 866: Line 653:
  
 
==E-GEMOX==
 
==E-GEMOX==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
E-GEMOX: '''<u>E</u>'''rlotinib, '''<u>GEM</u>'''citabine, '''<u>OX</u>'''aliplatin
 
E-GEMOX: '''<u>E</u>'''rlotinib, '''<u>GEM</u>'''citabine, '''<u>OX</u>'''aliplatin
 
===Regimen===
 
===Regimen===
Line 879: Line 663:
  
 
==FAP==
 
==FAP==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
FAP: '''<u>F</u>'''luorouracil, '''<u>A</u>'''lfa interferon, '''<u>P</u>'''latinol (Cisplatin)
 
FAP: '''<u>F</u>'''luorouracil, '''<u>A</u>'''lfa interferon, '''<u>P</u>'''latinol (Cisplatin)
 
===Regimen===
 
===Regimen===
Line 892: Line 673:
  
 
==FEC & HP==
 
==FEC & HP==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
FEC & HP: '''<u>F</u>'''luorouracil, '''<u>E</u>'''pirubicin, '''<u>C</u>'''yclophosphamide, '''<u>H</u>'''erceptin (Trastuzumab), '''<u>P</u>'''ertuzumab
 
FEC & HP: '''<u>F</u>'''luorouracil, '''<u>E</u>'''pirubicin, '''<u>C</u>'''yclophosphamide, '''<u>H</u>'''erceptin (Trastuzumab), '''<u>P</u>'''ertuzumab
 
===Regimen===
 
===Regimen===
Line 907: Line 685:
  
 
==FLA==
 
==FLA==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
FLA: '''<u>FL</u>'''udarabine & '''<u>A</u>'''ra-C (Cytarabine)
 
FLA: '''<u>FL</u>'''udarabine & '''<u>A</u>'''ra-C (Cytarabine)
 
===Regimen===
 
===Regimen===
Line 918: Line 693:
  
 
==FLAG-Ida & GO==
 
==FLAG-Ida & GO==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
FLAG-Ida & GO: '''<u>FL</u>'''udarabine, '''<u>A</u>'''ra-C (Cytarabine), '''<u>G</u>'''-CSF (Lenograstim), '''<u>Ida</u>'''rubicin, '''<u>G</u>'''emtuzumab '''<u>O</u>'''zogamicin
 
FLAG-Ida & GO: '''<u>FL</u>'''udarabine, '''<u>A</u>'''ra-C (Cytarabine), '''<u>G</u>'''-CSF (Lenograstim), '''<u>Ida</u>'''rubicin, '''<u>G</u>'''emtuzumab '''<u>O</u>'''zogamicin
 
===Regimen {{#subobject:44e85e|Variant=1}}===
 
===Regimen {{#subobject:44e85e|Variant=1}}===
Line 935: Line 707:
  
 
==FLAI==
 
==FLAI==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
FLAI: '''<u>FL</u>'''udarabine, '''<u>A</u>'''ra-C (Cytarabine), '''<u>I</u>'''darubicin
 
FLAI: '''<u>FL</u>'''udarabine, '''<u>A</u>'''ra-C (Cytarabine), '''<u>I</u>'''darubicin
 
<br>FIA: '''<u>F</u>'''ludarabine, '''<u>I</u>'''darubicin, '''<u>A</u>'''ra-C (Cytarabine)
 
<br>FIA: '''<u>F</u>'''ludarabine, '''<u>I</u>'''darubicin, '''<u>A</u>'''ra-C (Cytarabine)
Line 948: Line 717:
  
 
==FOLF-CB==
 
==FOLF-CB==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
FOLF-CB: '''<u>FOL</u>'''inic acid, '''<u>F</u>'''luorouracil, '''<u>C</u>'''etuximab, '''<u>B</u>'''evacizumab
 
FOLF-CB: '''<u>FOL</u>'''inic acid, '''<u>F</u>'''luorouracil, '''<u>C</u>'''etuximab, '''<u>B</u>'''evacizumab
 
===Regimen===
 
===Regimen===
Line 962: Line 728:
  
 
==FOLFIRI & Regorafenib==
 
==FOLFIRI & Regorafenib==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
FOLFIRI & Regorafenib: '''<u>FOL</u>'''inic acid, '''<u>F</u>'''luorouracil, '''<u>IRI</u>'''notecan, Regorafenib
 
FOLFIRI & Regorafenib: '''<u>FOL</u>'''inic acid, '''<u>F</u>'''luorouracil, '''<u>IRI</u>'''notecan, Regorafenib
 
===Regimen===
 
===Regimen===
Line 976: Line 739:
  
 
==FOLFIRI & Simvastatin==
 
==FOLFIRI & Simvastatin==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
FOLFIRI & Simvastatin: '''<u>FOL</u>'''inic acid, '''<u>F</u>'''luorouracil, '''<u>IRI</u>'''notecan, Simvastatin
 
FOLFIRI & Simvastatin: '''<u>FOL</u>'''inic acid, '''<u>F</u>'''luorouracil, '''<u>IRI</u>'''notecan, Simvastatin
 
===Regimen===
 
===Regimen===
Line 990: Line 750:
  
 
==FOLFIRI & Sunitinib==
 
==FOLFIRI & Sunitinib==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
FOLFIRI & Sunitinib: '''<u>FOL</u>'''inic acid, '''<u>F</u>'''luorouracil, '''<u>IRI</u>'''notecan, Sunitinib
 
FOLFIRI & Sunitinib: '''<u>FOL</u>'''inic acid, '''<u>F</u>'''luorouracil, '''<u>IRI</u>'''notecan, Sunitinib
 
===Regimen===
 
===Regimen===
Line 1,004: Line 761:
  
 
==FULV & Trimetrexate==
 
==FULV & Trimetrexate==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
FULV & Trimetrexate: 5-'''<u>FU</u>''' & '''<u>L</u>'''euco'''<u>V</u>'''orin (Folinic acid), Trimetrexate
 
FULV & Trimetrexate: 5-'''<u>FU</u>''' & '''<u>L</u>'''euco'''<u>V</u>'''orin (Folinic acid), Trimetrexate
 
===Regimen===
 
===Regimen===
Line 1,016: Line 770:
  
 
==GVP==
 
==GVP==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
GVP: '''<u>G</u>'''emcitabine, '''<u>V</u>'''inorelbine, '''<u>P</u>'''latinol (Cisplatin)
 
GVP: '''<u>G</u>'''emcitabine, '''<u>V</u>'''inorelbine, '''<u>P</u>'''latinol (Cisplatin)
 
===Regimen===
 
===Regimen===
Line 1,028: Line 779:
  
 
==ICE, ATRA, GO==
 
==ICE, ATRA, GO==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
ICE, ATRA: '''<u>I</u>'''darubicin, '''<u>C</u>'''ytarabine, '''<u>E</u>'''toposide, '''<u>A</u>'''ll-'''<u>T</u>'''rans '''<u>R</u>'''etinoic '''<u>A</u>'''cid, '''<u>G</u>'''emtuzumab '''<u>O</u>'''zogamicin
 
ICE, ATRA: '''<u>I</u>'''darubicin, '''<u>C</u>'''ytarabine, '''<u>E</u>'''toposide, '''<u>A</u>'''ll-'''<u>T</u>'''rans '''<u>R</u>'''etinoic '''<u>A</u>'''cid, '''<u>G</u>'''emtuzumab '''<u>O</u>'''zogamicin
 
===Regimen===
 
===Regimen===
Line 1,043: Line 791:
  
 
==Ixabepilone & Bevacizumab==
 
==Ixabepilone & Bevacizumab==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Chemotherapy====
 
====Chemotherapy====
Line 1,054: Line 799:
  
 
==ME==
 
==ME==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
ME: '''<u>M</u>'''itoxantrone & '''<u>E</u>'''toposide
 
ME: '''<u>M</u>'''itoxantrone & '''<u>E</u>'''toposide
 
===Regimen===
 
===Regimen===
Line 1,065: Line 807:
  
 
==MEV==
 
==MEV==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
MEV: '''<u>M</u>'''itomycin, '''<u>E</u>'''toposide, '''<u>V</u>'''indesine
 
MEV: '''<u>M</u>'''itomycin, '''<u>E</u>'''toposide, '''<u>V</u>'''indesine
 
===Regimen===
 
===Regimen===
Line 1,077: Line 816:
  
 
==MFL==
 
==MFL==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
MFL: '''<u>M</u>'''ethyl-lomustine (MeCCNU), 5-'''<u>F</u>'''U, '''<u>L</u>'''eucovorin (Folinic acid)
 
MFL: '''<u>M</u>'''ethyl-lomustine (MeCCNU), 5-'''<u>F</u>'''U, '''<u>L</u>'''eucovorin (Folinic acid)
 
===Regimen===
 
===Regimen===
Line 1,089: Line 825:
  
 
==MFT==
 
==MFT==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
MFL: '''<u>M</u>'''ethotrexate, 5-'''<u>F</u>'''U, '''<u>T</u>'''amoxifen
 
MFL: '''<u>M</u>'''ethotrexate, 5-'''<u>F</u>'''U, '''<u>T</u>'''amoxifen
 
===Regimen===
 
===Regimen===
Line 1,102: Line 835:
  
 
==Mitoxantrone & Hydrocortisone==
 
==Mitoxantrone & Hydrocortisone==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Chemotherapy====
 
====Chemotherapy====
Line 1,113: Line 843:
  
 
==MMF==
 
==MMF==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
MMF: '''<u>M</u>'''ethyl-lomustine (MeCCNU), '''<u>M</u>'''itomycin, 5-'''<u>F</u>'''U
 
MMF: '''<u>M</u>'''ethyl-lomustine (MeCCNU), '''<u>M</u>'''itomycin, 5-'''<u>F</u>'''U
 
===Regimen===
 
===Regimen===
Line 1,125: Line 852:
  
 
==MPP==
 
==MPP==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
MPP: '''<u>M</u>'''elphalan, '''<u>P</u>'''rednisone, '''<u>P</u>'''rocarbazine
 
MPP: '''<u>M</u>'''elphalan, '''<u>P</u>'''rednisone, '''<u>P</u>'''rocarbazine
 
===Regimen===
 
===Regimen===
Line 1,137: Line 861:
  
 
==MTP==
 
==MTP==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
MTP: '''<u>M</u>'''yocet (Non-pegylated liposomal doxorubicin), '''<u>T</u>'''rastuzumab, '''<u>P</u>'''aclitaxel
 
MTP: '''<u>M</u>'''yocet (Non-pegylated liposomal doxorubicin), '''<u>T</u>'''rastuzumab, '''<u>P</u>'''aclitaxel
 
===Regimen===
 
===Regimen===
Line 1,150: Line 871:
  
 
==MVC==
 
==MVC==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
MVC: '''<u>M</u>'''itomycin, '''<u>V</u>'''indesine, '''<u>C</u>'''arboplatin
 
MVC: '''<u>M</u>'''itomycin, '''<u>V</u>'''indesine, '''<u>C</u>'''arboplatin
 
===Regimen===
 
===Regimen===
Line 1,162: Line 880:
  
 
==NIP==
 
==NIP==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
NIP: '''<u>N</u>'''avelbine (Vinorelbine), '''<u>I</u>'''fosfamide, '''<u>P</u>'''latinol (Cisplatin)
 
NIP: '''<u>N</u>'''avelbine (Vinorelbine), '''<u>I</u>'''fosfamide, '''<u>P</u>'''latinol (Cisplatin)
 
===Regimen===
 
===Regimen===
Line 1,174: Line 889:
  
 
==PD & Pembrolizumab==
 
==PD & Pembrolizumab==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
PD & Pembrolizumab: '''<u>P</u>'''omalidomide, '''<u>D</u>'''examethasone, Pembrolizumab
 
PD & Pembrolizumab: '''<u>P</u>'''omalidomide, '''<u>D</u>'''examethasone, Pembrolizumab
 
===Regimen===
 
===Regimen===
Line 1,202: Line 914:
  
 
==PEI==
 
==PEI==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
PEI: '''<u>P</u>'''latinol (Cisplatin), '''<u>E</u>'''toposide, '''<u>I</u>'''fosfamide
 
PEI: '''<u>P</u>'''latinol (Cisplatin), '''<u>E</u>'''toposide, '''<u>I</u>'''fosfamide
 
===Regimen===
 
===Regimen===
Line 1,214: Line 923:
  
 
==PELF==
 
==PELF==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
PELF: '''<u>P</u>'''latinol (Cisplatin), '''<u>E</u>'''pirubicin, '''<u>L</u>'''eucovorin, 5-'''<u>F</u>'''U
 
PELF: '''<u>P</u>'''latinol (Cisplatin), '''<u>E</u>'''pirubicin, '''<u>L</u>'''eucovorin, 5-'''<u>F</u>'''U
 
===Regimen===
 
===Regimen===
Line 1,227: Line 933:
  
 
==PGT==
 
==PGT==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
PGT: '''<u>P</u>'''latinol (Cisplatin), '''<u>G</u>'''emcitabine, '''<u>T</u>'''axol (Paclitaxel)
 
PGT: '''<u>P</u>'''latinol (Cisplatin), '''<u>G</u>'''emcitabine, '''<u>T</u>'''axol (Paclitaxel)
 
===Regimen===
 
===Regimen===
Line 1,239: Line 942:
  
 
==PGV==
 
==PGV==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
PGV: '''<u>P</u>'''latinol (Cisplatin), '''<u>G</u>'''emcitabine, '''<u>V</u>'''inorelbine
 
PGV: '''<u>P</u>'''latinol (Cisplatin), '''<u>G</u>'''emcitabine, '''<u>V</u>'''inorelbine
 
<br>CGV: '''<u>C</u>'''isplatin, '''<u>G</u>'''emcitabine, '''<u>V</u>'''inorelbine
 
<br>CGV: '''<u>C</u>'''isplatin, '''<u>G</u>'''emcitabine, '''<u>V</u>'''inorelbine
Line 1,252: Line 952:
  
 
==Pemetrexed & Cetuximab==
 
==Pemetrexed & Cetuximab==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Chemotherapy====
 
====Chemotherapy====
Line 1,263: Line 960:
  
 
==Pemetrexed & Vandetanib==
 
==Pemetrexed & Vandetanib==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Chemotherapy====
 
====Chemotherapy====
Line 1,274: Line 968:
  
 
==Pixantrone & Rituximab==
 
==Pixantrone & Rituximab==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Chemotherapy====
 
====Chemotherapy====
Line 1,285: Line 976:
  
 
==PVI==
 
==PVI==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
PVI: '''<u>P</u>'''latinol (Cisplatin), '''<u>V</u>'''indesine, '''<u>I</u>'''fosfamide
 
PVI: '''<u>P</u>'''latinol (Cisplatin), '''<u>V</u>'''indesine, '''<u>I</u>'''fosfamide
 
<br>VIP: '''<u>V</u>'''indesine, '''<u>I</u>'''fosfamide, '''<u>P</u>'''latinol (Cisplatin)
 
<br>VIP: '''<u>V</u>'''indesine, '''<u>I</u>'''fosfamide, '''<u>P</u>'''latinol (Cisplatin)
Line 1,312: Line 1,000:
  
 
==R-MegaCHOEP==
 
==R-MegaCHOEP==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
R-MegaCHOEP: '''<u>R</u>'''ituximab, high-dose ('''<u>Mega</u>''') '''<u>C</u>'''yclophosphamide, '''<u>H</u>'''ydroxydaunorubicin (Doxorubicin), '''<u>O</u>'''ncovin (Vincristine), '''<u>E</u>'''toposide, '''<u>P</u>'''rednisone
 
R-MegaCHOEP: '''<u>R</u>'''ituximab, high-dose ('''<u>Mega</u>''') '''<u>C</u>'''yclophosphamide, '''<u>H</u>'''ydroxydaunorubicin (Doxorubicin), '''<u>O</u>'''ncovin (Vincristine), '''<u>E</u>'''toposide, '''<u>P</u>'''rednisone
 
====Targeted therapy====
 
====Targeted therapy====
Line 1,327: Line 1,012:
  
 
==Realgar-Indigo naturalis formula monotherapy==
 
==Realgar-Indigo naturalis formula monotherapy==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Targeted therapy====
 
====Targeted therapy====
Line 1,336: Line 1,018:
  
 
==TCG==
 
==TCG==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
TCG: '''<u>T</u>'''axol (Paclitaxel), '''<u>C</u>'''arboplatin, '''<u>G</u>'''emcitabine
 
TCG: '''<u>T</u>'''axol (Paclitaxel), '''<u>C</u>'''arboplatin, '''<u>G</u>'''emcitabine
 
===Regimen===
 
===Regimen===
Line 1,348: Line 1,027:
  
 
==TCHL (Docetaxel)==
 
==TCHL (Docetaxel)==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
TCHL: '''<u>T</u>'''axotere (Docetaxel), '''<u>C</u>'''arboplatin, '''<u>H</u>'''erceptin (Trastuzumab), '''<u>L</u>'''apatinib
 
TCHL: '''<u>T</u>'''axotere (Docetaxel), '''<u>C</u>'''arboplatin, '''<u>H</u>'''erceptin (Trastuzumab), '''<u>L</u>'''apatinib
 
===Regimen===
 
===Regimen===
Line 1,362: Line 1,038:
  
 
==TCL (Docetaxel)==
 
==TCL (Docetaxel)==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
TCL: '''<u>T</u>'''axotere (Docetaxel), '''<u>C</u>'''arboplatin, '''<u>L</u>'''apatinib
 
TCL: '''<u>T</u>'''axotere (Docetaxel), '''<u>C</u>'''arboplatin, '''<u>L</u>'''apatinib
 
===Regimen===
 
===Regimen===
Line 1,375: Line 1,048:
  
 
==TEC==
 
==TEC==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
TEC: '''<u>T</u>'''axol (Paclitaxel), '''<u>E</u>'''pirubicin, '''<u>C</u>'''arboplatin
 
TEC: '''<u>T</u>'''axol (Paclitaxel), '''<u>E</u>'''pirubicin, '''<u>C</u>'''arboplatin
 
===Regimen===
 
===Regimen===
Line 1,387: Line 1,057:
  
 
==TG+Bev==
 
==TG+Bev==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
TG+Bev: '''<u>T</u>'''axotere (Docetaxel), '''<u>G</u>'''emcitabine, '''<u>Bev</u>'''acizumab
 
TG+Bev: '''<u>T</u>'''axotere (Docetaxel), '''<u>G</u>'''emcitabine, '''<u>Bev</u>'''acizumab
 
===Regimen===
 
===Regimen===
Line 1,400: Line 1,067:
  
 
==Paclitaxel & Trastuzumab (TH) & Everolimus {{#subobject:aa22dd|Regimen=1}}==
 
==Paclitaxel & Trastuzumab (TH) & Everolimus {{#subobject:aa22dd|Regimen=1}}==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
TH & Everolimus: '''<u>T</u>'''axol (Paclitaxel), '''<u>H</u>'''erceptin (Trastuzumab), Everolimus
 
TH & Everolimus: '''<u>T</u>'''axol (Paclitaxel), '''<u>H</u>'''erceptin (Trastuzumab), Everolimus
 
===Regimen===
 
===Regimen===
Line 1,413: Line 1,077:
  
 
==TPCV==
 
==TPCV==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
TPCV: '''<u>T</u>'''hioguanine, '''<u>P</u>'''rocarbazine, '''<u>C</u>'''CNU, '''<u>V</u>'''incristine
 
TPCV: '''<u>T</u>'''hioguanine, '''<u>P</u>'''rocarbazine, '''<u>C</u>'''CNU, '''<u>V</u>'''incristine
 
===Regimen===
 
===Regimen===
Line 1,426: Line 1,087:
  
 
==TX+Bev==
 
==TX+Bev==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
TX+Bev: '''<u>T</u>'''axotere (Docetaxel), '''<u>X</u>'''eloda (Capecitabine), '''<u>Bev</u>'''acizumab
 
TX+Bev: '''<u>T</u>'''axotere (Docetaxel), '''<u>X</u>'''eloda (Capecitabine), '''<u>Bev</u>'''acizumab
 
===Regimen===
 
===Regimen===
Line 1,439: Line 1,097:
  
 
==VADx==
 
==VADx==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
VADx: '''<u>V</u>'''incristine, '''<u>A</u>'''ra-C (Cytarabine), '''<u>D</u>'''e'''<u>x</u>'''amethasone
 
VADx: '''<u>V</u>'''incristine, '''<u>A</u>'''ra-C (Cytarabine), '''<u>D</u>'''e'''<u>x</u>'''amethasone
 
===Regimen===
 
===Regimen===
Line 1,451: Line 1,106:
  
 
==VAPEC-B==
 
==VAPEC-B==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
VAPEC-B: '''<u>V</u>'''incristine, '''<u>A</u>'''driamycin (Doxorubicin), '''<u>P</u>'''rednisolone, '''<u>E</u>'''toposide, '''<u>C</u>'''yclophosphamide, '''<u>B</u>'''leomycin
 
VAPEC-B: '''<u>V</u>'''incristine, '''<u>A</u>'''driamycin (Doxorubicin), '''<u>P</u>'''rednisolone, '''<u>E</u>'''toposide, '''<u>C</u>'''yclophosphamide, '''<u>B</u>'''leomycin
 
===Regimen===
 
===Regimen===
Line 1,466: Line 1,118:
  
 
==VBM (Vinblastine)==
 
==VBM (Vinblastine)==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
VBM: '''<u>V</u>'''inblastine, '''<u>B</u>'''leomycin, '''<u>M</u>'''ethotrexate
 
VBM: '''<u>V</u>'''inblastine, '''<u>B</u>'''leomycin, '''<u>M</u>'''ethotrexate
 
===Regimen===
 
===Regimen===
Line 1,478: Line 1,127:
  
 
==VCE==
 
==VCE==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
VCE: '''<u>V</u>'''incristine, '''<u>C</u>'''arboplatin, '''<u>E</u>'''toposide
 
VCE: '''<u>V</u>'''incristine, '''<u>C</u>'''arboplatin, '''<u>E</u>'''toposide
 
===Regimen===
 
===Regimen===
Line 1,490: Line 1,136:
  
 
==Vinorelbine & Hydrocortisone==
 
==Vinorelbine & Hydrocortisone==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Chemotherapy====
 
====Chemotherapy====
Line 1,501: Line 1,144:
  
 
==VNC==
 
==VNC==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
VNC: '''<u>V</u>'''incristine, '''<u>N</u>'''ovantrone (Mitoxantrone), '''<u>C</u>'''yclophosphamide
 
VNC: '''<u>V</u>'''incristine, '''<u>N</u>'''ovantrone (Mitoxantrone), '''<u>C</u>'''yclophosphamide
 
===Regimen===
 
===Regimen===
Line 1,513: Line 1,153:
  
 
==VPV==
 
==VPV==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
VPV: '''<u>V</u>'''inblastine, '''<u>P</u>'''latinol (Cisplatin), '''<u>V</u>'''P-16 (Etoposide)
 
VPV: '''<u>V</u>'''inblastine, '''<u>P</u>'''latinol (Cisplatin), '''<u>V</u>'''P-16 (Etoposide)
 
===Regimen===
 
===Regimen===
Line 1,525: Line 1,162:
  
 
==VTDC==
 
==VTDC==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
VTDC: '''<u>V</u>'''elcade (Bortezomib), '''<u>T</u>'''halidomide, '''<u>D</u>'''examethasone, '''<u>C</u>'''yclophosphamide
 
VTDC: '''<u>V</u>'''elcade (Bortezomib), '''<u>T</u>'''halidomide, '''<u>D</u>'''examethasone, '''<u>C</u>'''yclophosphamide
 
===Regimen===
 
===Regimen===
Line 1,540: Line 1,174:
 
=Regimens that contain experimental (unapproved) drugs=
 
=Regimens that contain experimental (unapproved) drugs=
 
==Adavosertib & Gemcitabine==
 
==Adavosertib & Gemcitabine==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Targeted therapy====
 
====Targeted therapy====
Line 1,551: Line 1,182:
  
 
==Alisertib monotherapy==
 
==Alisertib monotherapy==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Targeted therapy====
 
====Targeted therapy====
Line 1,560: Line 1,188:
  
 
==Amonafide & Cytarabine==
 
==Amonafide & Cytarabine==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Chemotherapy====
 
====Chemotherapy====
Line 1,570: Line 1,195:
  
 
==Buparlisib & Fulvestrant==
 
==Buparlisib & Fulvestrant==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Targeted therapy====
 
====Targeted therapy====
Line 1,581: Line 1,203:
  
 
==Buparlisib & Paclitaxel==
 
==Buparlisib & Paclitaxel==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Targeted therapy====
 
====Targeted therapy====
Line 1,592: Line 1,211:
  
 
==Carboplatin & Paclitaxel (CP) & Cediranib==
 
==Carboplatin & Paclitaxel (CP) & Cediranib==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
CP & Cediranib: '''<u>C</u>'''arboplatin, '''<u>P</u>'''aclitaxel, Cediranib
 
CP & Cediranib: '''<u>C</u>'''arboplatin, '''<u>P</u>'''aclitaxel, Cediranib
 
===Regimen===
 
===Regimen===
Line 1,605: Line 1,221:
  
 
==Carboplatin & Paclitaxel (CP) & Trebananib==
 
==Carboplatin & Paclitaxel (CP) & Trebananib==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
TC & Trebananib: '''<u>T</u>'''axol (Paclitaxel), '''<u>C</u>'''arboplatin, Trebananib
 
TC & Trebananib: '''<u>T</u>'''axol (Paclitaxel), '''<u>C</u>'''arboplatin, Trebananib
 
===Regimen===
 
===Regimen===
Line 1,632: Line 1,245:
  
 
==Carboplatin & Paclitaxel (CP) & Veliparib==
 
==Carboplatin & Paclitaxel (CP) & Veliparib==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
CP & Veliparib: '''<u>C</u>'''arboplatin, '''<u>P</u>'''aclitaxel, Veliparib
 
CP & Veliparib: '''<u>C</u>'''arboplatin, '''<u>P</u>'''aclitaxel, Veliparib
 
===Regimen===
 
===Regimen===
Line 1,645: Line 1,255:
  
 
==Cediranib monotherapy==
 
==Cediranib monotherapy==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Targeted therapy====
 
====Targeted therapy====
Line 1,654: Line 1,261:
  
 
==Docetaxel & Bavituximab==
 
==Docetaxel & Bavituximab==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Chemotherapy====
 
====Chemotherapy====
Line 1,665: Line 1,269:
  
 
==Docetaxel & Ganetespib==
 
==Docetaxel & Ganetespib==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Chemotherapy====
 
====Chemotherapy====
Line 1,676: Line 1,277:
  
 
==Erlotinib & Figitumumab==
 
==Erlotinib & Figitumumab==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Targeted therapy====
 
====Targeted therapy====
Line 1,686: Line 1,284:
  
 
==Erlotinib & Onartuzumab==
 
==Erlotinib & Onartuzumab==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Targeted therapy====
 
====Targeted therapy====
Line 1,696: Line 1,291:
  
 
==Erlotinib & Tivantinib==
 
==Erlotinib & Tivantinib==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Targeted therapy====
 
====Targeted therapy====
Line 1,706: Line 1,298:
  
 
==Cisplatin & Gemcitabine (GC) & Veliparib==
 
==Cisplatin & Gemcitabine (GC) & Veliparib==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
GC & Veliparib: '''<u>G</u>'''emcitabine, '''<u>C</u>'''isplatin, Veliparib
 
GC & Veliparib: '''<u>G</u>'''emcitabine, '''<u>C</u>'''isplatin, Veliparib
 
===Regimen===
 
===Regimen===
Line 1,719: Line 1,308:
  
 
==Ibrutinib & Ublituximab==
 
==Ibrutinib & Ublituximab==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
====Targeted therapy====
 
====Targeted therapy====
Line 1,729: Line 1,315:
  
 
==Pegylated liposomal doxorubicin & Trebananib==
 
==Pegylated liposomal doxorubicin & Trebananib==
−
{| class="wikitable" style="float:right; margin-left: 5px;"
+
 
−
|-
 
−
|[[#top|back to top]]
 
−
|}
 
 
===Regimen===
 
===Regimen===
 
{| class="wikitable sortable" style="width: 100%; text-align:center;"  
 
{| class="wikitable sortable" style="width: 100%; text-align:center;"  

Revision as of 00:25, 27 July 2022

Back to Top

Regimens that have not proven to be superior to a standard-of-care comparison and are thus unlikely to be expanded upon unless new evidence comes forward. This page is primarily to drive the HemOnc Ontology and for historic interest.


Regimens composed solely of approved drugs

3M

3M: Mitomycin, Mitoxantrone, Methotrexate

Regimen

Chemotherapy

5-FU & RT

Regimen

Chemotherapy

Radiotherapy

7+3i & Clofarabine

7+3i & Clofarabine: 7 days of cytarabine, 3 days of idarubicin, Clofarabine

Regimen

Chemotherapy

7+3i & Lenalidomide

7+3i & Lenalidomide: 7 days of cytarabine, 3 days of idarubicin, Lenalidomide

Regimen

Chemotherapy

Targeted therapy

7+4i

7+4i: 7 days of cytarabine, 4 days of idarubicin

Regimen

Chemotherapy

7+5d

7+5d: 7 days of cytarabine, 5 days of daunorubicin

Regimen

Chemotherapy

Abiraterone & Enzalutamide

Regimen

Endocrine therapy

ABVP

Regimen

Chemotherapy

ACP

ACP: Atezolizumab, Carboplatin, Paclitaxel

Regimen

Immunotherapy

Chemotherapy

Afatinib & Vinorelbine

Regimen

Chemotherapy

Targeted therapy

A-ICE

A-ICE: ATRA, Idarubicin, Cytarabine, Etoposide

Regimen

Targeted therapy

Chemotherapy

AME

AME: Ara-C (Cytarabine), Mitoxantrone, Etoposide

Regimen

Chemotherapy

Amsacrine & IDAC

Amsacrine & IDAC: Amsacrine & Intermediate Dose Ara-C (Cytarabine)

Regimen

Chemotherapy

ATRA, Cytarabine, Etoposide

Regimen

Targeted therapy

Chemotherapy

AVML

Regimen

Chemotherapy

Supportive therapy

Binimetinib monotherapy

Regimen

Targeted therapy

Bortezomib & Bevacizumab

Regimen

Study Years of enrollment Evidence Comparator Comparative Efficacy
White et al. 2012 (AMBER) 2007-2009 Randomized Phase 2 (E-esc) Bortezomib Did not meet primary endpoint of PFS
(HR 0.74, 95% CI 0.43-1.28)

Targeted therapy

Bortezomib & Siltuximab

Regimen

Study Years of enrollment Evidence Comparator Comparative Efficacy
Orlowski et al. 2015 (CR012784) 2006-2009 Randomized Phase 2 (E-esc) Bortezomib Did not meet primary endpoint of PFS
(HR 0.87, 95% CI 0.65-1.16)

Targeted therapy

BTH (Docetaxel)

BTH: Bevacizumab, Taxotere (Docetaxel), Herceptin (Trastuzumab)

Regimen

Chemotherapy

Targeted therapy

BTOC

BTOC: BCNU, Thiotepa, Oncovin (Vincristine), Cyclophosphamide

Regimen

Chemotherapy

CAD

CAD: Cyclophosphamide, Adriamycin (Doxorubicin), DDP (Cisplatin)

Regimen

Chemotherapy

Capecitabine & Cisplatin (CX) & Bevacizumab

Regimen

Chemotherapy

Targeted therapy

Capecitabine & Cisplatin (CX) & Ramucirumab

Regimen

Chemotherapy

Targeted therapy

Capecitabine & Ruxolitinib

Regimen

Chemotherapy

Targeted therapy

Capecitabine & Sorafenib

Regimen

Chemotherapy

Targeted therapy

Capecitabine & Sunitinib

Regimen

Chemotherapy

Targeted therapy

Capecitabine & Vinflunine

Regimen

Chemotherapy

Capecitabine & Vinorelbine (NX)

NX: Navelbine (Vinorelbine) & Xeloda (Capecitabine)

Regimen

Chemotherapy

Capecitabine, Cisplatin, Cetuximab, RT

Regimen

Chemotherapy

Targeted therapy

Radiotherapy

Capecitabine, Erlotinib, RT

Regimen

Chemotherapy

Targeted therapy

Radiotherapy

CarboMIP

CarboMIP: Carboplatin, Mitomycin, Ifosfamide, Platinol (Cisplatin)

Regimen

Chemotherapy

Carboplatin & Epirubicin

Regimen

Chemotherapy

Carboplatin & Paclitaxel (CP) & Bexarotene

CP & Bexarotene: Carboplatin, Paclitaxel, Bexarotene

Regimen

Chemotherapy

Carboplatin & Paclitaxel (CP) & Cetuximab

CP & Cetuximab: Carboplatin, Paclitaxel, Cetuximab

Regimen

Chemotherapy

Targeted therapy

Carboplatin & Paclitaxel (CP) & Erlotinib

CP & Erlotinib: Carboplatin, Paclitaxel, Erlotinib

Regimen

Chemotherapy

Targeted therapy

Carboplatin & Paclitaxel (CP) & Pegylated liposomal doxorubicin

CP & PLD: Carboplatin, Paclitaxel, Pegylated Liposomal Doxorubicin
TC & PLD: Taxol (Paclitaxel), Carboplatin, Pegylated Liposomal Doxorubicin

Regimen

Chemotherapy

Carboplatin & Paclitaxel (CP) & Sorafenib

CP & Sorafenib: Carboplatin, Paclitaxel, Sorafenib

Regimen

Chemotherapy

Targeted therapy

Carboplatin & Paclitaxel (CP) & Topotecan

TC & Topotecan: Taxol (Paclitaxel), Carboplatin, Topotecan

Regimen

Chemotherapy

Carboplatin & Topotecan

Regimen

Chemotherapy

CBM

CBM: Capecitabine, Bevacizumab, Mitomycin

Regimen

Chemotherapy

Targeted therapy

CCG

CCG: Cisplatin, Carboplatin, Gemcitabine

Regimen

Chemotherapy

Carboplatin & Etoposide (CE) & Ipilimumab

CE & Ipilimumab: Carboplatin, Etoposide, Ipilimumab

Regimen

Chemotherapy

Immunotherapy

Carboplatin & Etoposide (CE) & Thalidomide

CE & Thalidomide: Carboplatin, Etoposide, Thalidomide

Regimen

Chemotherapy

Targeted therapy

CIB

CIB: Cisplatin, Ifosfamide, Bleomycin

Regimen

Chemotherapy

Cisplatin & Methotrexate

Regimen

Chemotherapy

Cisplatin & Treosulfan

Regimen

Chemotherapy

Cisplatin & Vincristine

Regimen

Chemotherapy

Cisplatin, Avelumab, RT

Regimen

Chemotherapy

Immunotherapy

Radiotherapy

Cisplatin, Pemetrexed, RT

Regimen

Chemotherapy

Radiotherapy

CODE

CODE: Cisplatin, Oncovin (Vincristine), Doxorubicin, Etoposide

Regimen

Chemotherapy

CYVADIC

CYVADIC: CYclophosphamide, Vincristine, ADriamycin (Doxorubicin), Imidazole Carboxamide (Dacarbazine)

Regimen

Chemotherapy

DBCT

DBCT: Dacarbazine, BCNU (Carmustine), Cisplatin, Tamoxifen

Regimen

Chemotherapy

Endocrine therapy

Docetaxel & Gefitinib

Regimen

Chemotherapy

Targeted therapy

Docetaxel & Lapatinib (TL)

TL: Taxotere (Docetaxel) & Lapatinib

Regimen

Chemotherapy

Targeted therapy

Docetaxel & Pertuzumab

Regimen

Chemotherapy

Targeted therapy

Docetaxel & Selumetinib

Regimen

Chemotherapy

Targeted therapy

Docetaxel & Sunitinib

Regimen

Chemotherapy

Targeted therapy

Docetaxel & ziv-Aflibercept

Regimen

Chemotherapy

Targeted therapy

Doxorubicin & Etoposide

Regimen

Chemotherapy

Doxorubicin & Paclitaxel

Regimen

Chemotherapy

Doxorubicin & Sorafenib

Regimen

Chemotherapy

Targeted therapy

Doxorubicin & Streptozocin

Regimen

Chemotherapy

Doxorubicin & Vinorelbine

Regimen

Chemotherapy

EAP

EAP: Etoposide, Adriamycin (Doxorubicin), Platinol (Cisplatin)

Regimen

Chemotherapy

ECVBP

ECVBP: Epirubicin, Cyclophosphamide, Vindesine, Bleomycin, Prednisone

Regimen

Chemotherapy

ELF

ELF: Etoposide, Leucovorin, 5-FU

Regimen

Chemotherapy

Encorafenib monotherapy

Regimen

Targeted therapy

EP & Ipilimumab

EP & Ipilimumab: Etoposide, Platinol (Cisplatin), Ipilimumab

Regimen

Chemotherapy

Immunotherapy

EP, Tamoxifen, RT

EP, Tamoxifen, RT: Etoposide, Platinol (Cisplatin), Tamoxifen, Radiation Therapy

Regimen

Chemotherapy

Endocrine therapy

Radiotherapy

Erlotinib & Sunitinib

Regimen

Targeted therapy

Everolimus & Vinorelbine

Regimen

Chemotherapy

Targeted therapy

E-GEMOX

E-GEMOX: Erlotinib, GEMcitabine, OXaliplatin

Regimen

Targeted therapy

Chemotherapy

FAP

FAP: Fluorouracil, Alfa interferon, Platinol (Cisplatin)

Regimen

Chemotherapy

Immunotherapy

FEC & HP

FEC & HP: Fluorouracil, Epirubicin, Cyclophosphamide, Herceptin (Trastuzumab), Pertuzumab

Regimen

Chemotherapy

Targeted therapy

FLA

FLA: FLudarabine & Ara-C (Cytarabine)

Regimen

Chemotherapy

FLAG-Ida & GO

FLAG-Ida & GO: FLudarabine, Ara-C (Cytarabine), G-CSF (Lenograstim), Idarubicin, Gemtuzumab Ozogamicin

Regimen

Chemotherapy

Growth factor therapy

Targeted therapy

FLAI

FLAI: FLudarabine, Ara-C (Cytarabine), Idarubicin
FIA: Fludarabine, Idarubicin, Ara-C (Cytarabine)

Regimen

Chemotherapy

FOLF-CB

FOLF-CB: FOLinic acid, Fluorouracil, Cetuximab, Bevacizumab

Regimen

Chemotherapy

Targeted therapy

FOLFIRI & Regorafenib

FOLFIRI & Regorafenib: FOLinic acid, Fluorouracil, IRInotecan, Regorafenib

Regimen

Chemotherapy

Targeted therapy

FOLFIRI & Simvastatin

FOLFIRI & Simvastatin: FOLinic acid, Fluorouracil, IRInotecan, Simvastatin

Regimen

Chemotherapy

Targeted therapy

FOLFIRI & Sunitinib

FOLFIRI & Sunitinib: FOLinic acid, Fluorouracil, IRInotecan, Sunitinib

Regimen

Chemotherapy

Targeted therapy

FULV & Trimetrexate

FULV & Trimetrexate: 5-FU & LeucoVorin (Folinic acid), Trimetrexate

Regimen

Chemotherapy

GVP

GVP: Gemcitabine, Vinorelbine, Platinol (Cisplatin)

Regimen

Chemotherapy

ICE, ATRA, GO

ICE, ATRA: Idarubicin, Cytarabine, Etoposide, All-Trans Retinoic Acid, Gemtuzumab Ozogamicin

Regimen

Chemotherapy

Targeted therapy

Ixabepilone & Bevacizumab

Regimen

Chemotherapy

Targeted therapy

ME

ME: Mitoxantrone & Etoposide

Regimen

Chemotherapy

MEV

MEV: Mitomycin, Etoposide, Vindesine

Regimen

Chemotherapy

MFL

MFL: Methyl-lomustine (MeCCNU), 5-FU, Leucovorin (Folinic acid)

Regimen

Chemotherapy

MFT

MFL: Methotrexate, 5-FU, Tamoxifen

Regimen

Chemotherapy

Endocrine therapy

Mitoxantrone & Hydrocortisone

Regimen

Chemotherapy

Endocrine therapy

MMF

MMF: Methyl-lomustine (MeCCNU), Mitomycin, 5-FU

Regimen

Chemotherapy

MPP

MPP: Melphalan, Prednisone, Procarbazine

Regimen

Chemotherapy

MTP

MTP: Myocet (Non-pegylated liposomal doxorubicin), Trastuzumab, Paclitaxel

Regimen

Chemotherapy

Targeted therapy

MVC

MVC: Mitomycin, Vindesine, Carboplatin

Regimen

Chemotherapy

NIP

NIP: Navelbine (Vinorelbine), Ifosfamide, Platinol (Cisplatin)

Regimen

Chemotherapy

PD & Pembrolizumab

PD & Pembrolizumab: Pomalidomide, Dexamethasone, Pembrolizumab

Regimen

Study Years of enrollment Evidence Comparator Comparative Efficacy
Mateos et al. 2019 (KEYNOTE-183) 2016-2017 Phase 3 (E-esc) PD Seems to have inferior PFS
(HR 1.53, 95% CI 1.05-2.22)

Targeted therapy

Chemotherapy

Immunotherapy

PEI

PEI: Platinol (Cisplatin), Etoposide, Ifosfamide

Regimen

Chemotherapy

PELF

PELF: Platinol (Cisplatin), Epirubicin, Leucovorin, 5-FU

Regimen

Chemotherapy

PGT

PGT: Platinol (Cisplatin), Gemcitabine, Taxol (Paclitaxel)

Regimen

Chemotherapy

PGV

PGV: Platinol (Cisplatin), Gemcitabine, Vinorelbine
CGV: Cisplatin, Gemcitabine, Vinorelbine

Regimen

Chemotherapy

Pemetrexed & Cetuximab

Regimen

Chemotherapy

Targeted therapy

Pemetrexed & Vandetanib

Regimen

Chemotherapy

Targeted therapy

Pixantrone & Rituximab

Regimen

Chemotherapy

Targeted therapy

PVI

PVI: Platinol (Cisplatin), Vindesine, Ifosfamide
VIP: Vindesine, Ifosfamide, Platinol (Cisplatin)

Regimen

Chemotherapy

R-BEACOPP

R-BEACOPP: Rituximab, Bleomycin, Etoposide, Adriamycin (Doxorubicin), Cyclophosphamide, Oncovin (Vincristine), Procarbazine, Prednisone

Regimen

Targeted therapy

Chemotherapy

R-MegaCHOEP

R-MegaCHOEP: Rituximab, high-dose (Mega) Cyclophosphamide, Hydroxydaunorubicin (Doxorubicin), Oncovin (Vincristine), Etoposide, Prednisone

Targeted therapy

Chemotherapy

Realgar-Indigo naturalis formula monotherapy

Regimen

Targeted therapy

TCG

TCG: Taxol (Paclitaxel), Carboplatin, Gemcitabine

Regimen

Chemotherapy

TCHL (Docetaxel)

TCHL: Taxotere (Docetaxel), Carboplatin, Herceptin (Trastuzumab), Lapatinib

Regimen

Chemotherapy

Targeted therapy

TCL (Docetaxel)

TCL: Taxotere (Docetaxel), Carboplatin, Lapatinib

Regimen

Chemotherapy

Targeted therapy

TEC

TEC: Taxol (Paclitaxel), Epirubicin, Carboplatin

Regimen

Chemotherapy

TG+Bev

TG+Bev: Taxotere (Docetaxel), Gemcitabine, Bevacizumab

Regimen

Chemotherapy

Targeted therapy

Paclitaxel & Trastuzumab (TH) & Everolimus

TH & Everolimus: Taxol (Paclitaxel), Herceptin (Trastuzumab), Everolimus

Regimen

Chemotherapy

Targeted therapy

TPCV

TPCV: Thioguanine, Procarbazine, CCNU, Vincristine

Regimen

Chemotherapy

TX+Bev

TX+Bev: Taxotere (Docetaxel), Xeloda (Capecitabine), Bevacizumab

Regimen

Chemotherapy

Targeted therapy

VADx

VADx: Vincristine, Ara-C (Cytarabine), Dexamethasone

Regimen

Chemotherapy

VAPEC-B

VAPEC-B: Vincristine, Adriamycin (Doxorubicin), Prednisolone, Etoposide, Cyclophosphamide, Bleomycin

Regimen

Chemotherapy

VBM (Vinblastine)

VBM: Vinblastine, Bleomycin, Methotrexate

Regimen

Chemotherapy

VCE

VCE: Vincristine, Carboplatin, Etoposide

Regimen

Chemotherapy

Vinorelbine & Hydrocortisone

Regimen

Chemotherapy

Endocrine therapy

VNC

VNC: Vincristine, Novantrone (Mitoxantrone), Cyclophosphamide

Regimen

Chemotherapy

VPV

VPV: Vinblastine, Platinol (Cisplatin), VP-16 (Etoposide)

Regimen

Chemotherapy

VTDC

VTDC: Velcade (Bortezomib), Thalidomide, Dexamethasone, Cyclophosphamide

Regimen

Targeted therapy

Chemotherapy

Regimens that contain experimental (unapproved) drugs

Adavosertib & Gemcitabine

Regimen

Targeted therapy

Chemotherapy

Alisertib monotherapy

Regimen

Targeted therapy

Amonafide & Cytarabine

Regimen

Chemotherapy

Buparlisib & Fulvestrant

Regimen

Targeted therapy

Endocrine therapy

Buparlisib & Paclitaxel

Regimen

Targeted therapy

Chemotherapy

Carboplatin & Paclitaxel (CP) & Cediranib

CP & Cediranib: Carboplatin, Paclitaxel, Cediranib

Regimen

Chemotherapy

Targeted therapy

Carboplatin & Paclitaxel (CP) & Trebananib

TC & Trebananib: Taxol (Paclitaxel), Carboplatin, Trebananib

Regimen

Study Years of enrollment Evidence Comparator Comparative Efficacy
Vergote et al. 2019 (TRINOVA-3) 2012-2014 Phase 3 (E-esc) TC Did not meet primary endpoint of PFS
(HR 0.93, 95% CI 0.79-1.09)

Chemotherapy

Targeted therapy

Carboplatin & Paclitaxel (CP) & Veliparib

CP & Veliparib: Carboplatin, Paclitaxel, Veliparib

Regimen

Chemotherapy

Targeted therapy

Cediranib monotherapy

Regimen

Targeted therapy

Docetaxel & Bavituximab

Regimen

Chemotherapy

Immunotherapy

Docetaxel & Ganetespib

Regimen

Chemotherapy

Targeted therapy

Erlotinib & Figitumumab

Regimen

Targeted therapy

Erlotinib & Onartuzumab

Regimen

Targeted therapy

Erlotinib & Tivantinib

Regimen

Targeted therapy

Cisplatin & Gemcitabine (GC) & Veliparib

GC & Veliparib: Gemcitabine, Cisplatin, Veliparib

Regimen

Chemotherapy

Targeted therapy

Ibrutinib & Ublituximab

Regimen

Targeted therapy

Pegylated liposomal doxorubicin & Trebananib

Regimen

Study Years of enrollment Evidence Comparator Comparative Efficacy
Marth et al. 2016 (TRINOVA-2) 2011-2013 Phase 3 (E-esc) PLD Did not meet primary endpoint of PFS
(HR 0.92, 95% CI 0.68-1.24)

Chemotherapy

Targeted therapy

Retrieved from "https://hemonc.org/w/index.php?title=Stub&oldid=57980"